MMC SILICONE GEL SHEETING MMC-91

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 08 report with the FDA on 1998-02-23 for MMC SILICONE GEL SHEETING MMC-91 manufactured by Cui Corporation.

Event Text Entries

[87112] Physician indicated that pt began to have signficiant blistering shortly after using gel sheeting. He believes that problem developed into full thickness skin necrosis due to secondary infection. Problem did not develop where sheeting was applied, but in areas nearby. Physician did not feel the device was involved, however he did not feel he could rule out the possiblity, so cui is reporting in good faith.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2021296-1998-00001
MDR Report Key151935
Report Source08
Date Received1998-02-23
Date of Report1998-02-21
Date of Event1998-01-04
Date Mfgr Received1998-01-26
Device Manufacturer Date1997-05-01
Date Added to Maude1998-02-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameMMC SILICONE GEL SHEETING
Generic NameSILICONE GEL SHEETING
Product CodeMDA
Date Received1998-02-23
Model NumberNA
Catalog NumberMMC-91
Lot Number3-105061
ID NumberNA
OperatorLAY USER/PATIENT
Device AvailabilityN
Device AgeNA
Device Eval'ed by MfgrR
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key148062
ManufacturerCUI CORPORATION
Manufacturer Address1160 MARK AVE CARPINTERIA CA 93013 US
Baseline Brand NameMMC SILICONE GEL SHEETING
Baseline Generic NameSILICONE GEL SHEETING
Baseline Model NoNA
Baseline Catalog NoMMC-91
Baseline IDNA
Baseline Device FamilySILICONE GEL SHEETING
Baseline Shelf Life ContainedN
Baseline Shelf Life [Months]NA
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK913140
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Other 1998-02-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.